Guangzhou Sino-Israel Bio-Industry Investment Fund
Overview
A Sino-Israeli investment fund established in 2016, focusing on cross-border investments in innovative biotech, drug development, and life sciences companies from Israel, Europe, and the USA that are in or approaching clinical stages and aspire to establish activities in China. The fund acts as a strategic partner, providing resources and networks for clinical trials, regulatory submissions, and commercialization in China.
Portfolio Companies
6
Website
gibf-bio.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Bioversys | Sep 2024 | Strategic | Lead |
| CarboFix Orthopedics | Mar 2016 | VC Round | Lead |
| Nectin Therapeutics | May 2024 | VC Round | Co-investor |
| Alpha Omega Engineering | Dec 2018 | VC Round | Lead |
| Vitalerter | - | Series A | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Guangzhou Sino-Israel Bio-Industry Investment Fund based?
Guangzhou Sino-Israel Bio-Industry Investment Fund is headquartered in Guangzhou, Guangdong, China.
When was Guangzhou Sino-Israel Bio-Industry Investment Fund founded?
Founding year information for Guangzhou Sino-Israel Bio-Industry Investment Fund is not publicly available.
How many portfolio companies does Guangzhou Sino-Israel Bio-Industry Investment Fund have?
Guangzhou Sino-Israel Bio-Industry Investment Fund has 6 portfolio companies in Caplight's dataset.
What are some companies in Guangzhou Sino-Israel Bio-Industry Investment Fund's portfolio?
Portfolio companies visible on Caplight include Bioversys, CarboFix Orthopedics, Nectin Therapeutics, Alpha Omega Engineering, Vitalerter.
What was Guangzhou Sino-Israel Bio-Industry Investment Fund's most recent investment shown here?
Guangzhou Sino-Israel Bio-Industry Investment Fund's most recent investment in this portfolio sample was in Bioversys in 2024.
What sectors does Guangzhou Sino-Israel Bio-Industry Investment Fund focus on?
Guangzhou Sino-Israel Bio-Industry Investment Fund focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech.
What company stages does Guangzhou Sino-Israel Bio-Industry Investment Fund focus on?
Stage focus information for Guangzhou Sino-Israel Bio-Industry Investment Fund is not publicly available.
What is Guangzhou Sino-Israel Bio-Industry Investment Fund's AUM?
Guangzhou Sino-Israel Bio-Industry Investment Fund's assets under management are estimated between $400.0M and $400.0M.